Advancing Formulation & Delivery

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of formulation & delivery.

In-Person & Online Events

Collaborate & Partner for a Better Future

Explore Formulation & Delivery

Unite with the formulation & delivery industry's foremost leaders and scientific experts through our year-round activities. Immerse yourself in cutting-edge scientific content that sparks thought-provoking insights, providing a unique perspective on the latest R&D trends and challenges.

Resources & Announcements

18/06/24 - TFF Pharmaceuticals and the Cleveland Clinic team up to advance multivalent influenza vaccine candidates into preclinical phases.
16/05/24 - Positive results from Aileron Therapeutics' ongoing Phase Ib clinical trial gives hope to patients diagnosed with idiopathic pulmonary fibrosis (IPF).
26/04/24 - A preclinical study conducted by a team of scientists at the Institute for Bioengineering of Catalonia highlights the therapeutic potential of nanorobots in bladder cancer treatment.
17/04/24 - Sangamo Therapeutics developed a novel capsid that achieved outstanding results in a preclinical study, this could have significant implications for treating neurological disorders.
13/03/24 - A preclinical study conducted by a group of researchers at the University of Pennsylvania shows promise in treating cystic fibrosis using RNA therapeutics.
11/03/24 - Advancements in RNA therapeutic delivery are extending beyond liver-specific treatments, addressing complex challenges and enabling broader applications in medicine. Innovations in lipid nanoparticles, RNA interference, and artificial intelligence are key to this progress, offering potential treatments for a range of diseases and moving closer to personalized medicine. Despite remaining challenges, these developments mark significant strides towards transformative patient care.

Online Activities

26/06/24, 16:00 BST | 8:00 PT | Science Exchange

Controlled Release Formulations

Presented by Moderator: Apoorva Sarode, Principal Scientist (Technology), Genentech Panellists: Yogeshwar Bachhav, Director, AiCuris Anti-infective Cures AG; René Holm, Professor, University of Southern Denmark
02/09/24 | Science Exchange

Excipients & Their Role In Drug Stability

01/10/24 | Science Exchange

Discovery of Novel Therapeutic Modalities

01/11/24 | Science Exchange

AI/ML: The Future Of Formulation & Delivery

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

Oxford Global PLUS


Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things formulation & delivery